BRISTOL MYERS SQUIBB CO (BMY)
Clinical trial NCT01437787 updates: 1. status: COMPLETED → TERMINATED 2. start date: 2011-12-01 → 2011-12-31 3. completion date: 2014-06-01 → 2014-06-30 4. primary completion date: 2014-06-01 → 2014-06-30
Clinical trial NCT01437787 updates: 1. status: COMPLETED → TERMINATED 2. start date: 2011-12-01 → 2011-12-31 3. completion date: 2014-06-01 → 2014-06-30 4. primary completion date: 2014-06-01 → 2014-06-30
Clinical trial NCT06043427 updates: 1. completion date: 2026-12-31 → 2027-07-31 2. primary completion date: 2026-06-30 → 2026-12-31
Clinical trial NCT06792435 updates: 1. status: RECRUITING → ACTIVE_NOT_RECRUITING 2. completion date: 2025-12-31 → 2027-06-30 3. primary completion date: 2025-06-30 → 2026-12-30 4. collaborators added: Evopoint Biosciences Inc.
Clinical trial NCT07580365 updates: 1. status: NOT_YET_RECRUITING → RECRUITING 2. start date: 2026-06-01 → 2026-06-30 3. collaborators added: Fondazione Don Carlo Gnocchi ETS 4. collaborators removed: Fondazione Don Carlo Gnocchi Onlus
Clinical trial NCT06710795: primary completion date: 2026-03-23 → 2026-07-28.
Clinical trial NCT05514132: completion date: 2026-03-31 → 2027-03-31.
Clinical trial NCT06085248 updates: 1. status: UNKNOWN → COMPLETED 2. completion date: 2024-03-01 → 2024-04-01 3. primary completion date: 2024-02-01 → 2024-03-22 4. enrollment: 44 → 45 participants 5. enrollment type: ESTIMATED → ACTUAL
Clinical trial NCT07187869 updates: 1. status: NOT_YET_RECRUITING → RECRUITING 2. start date: 2026-03-31 → 2026-02-12
Clinical trial NCT07444450: status: NOT_YET_RECRUITING → RECRUITING.
Clinical trial NCT06131983 updates: 1. start date: 2024-02-22 → 2024-06-19 2. completion date: 2026-12-01 → 2028-12-31 3. primary completion date: 2026-12-01 → 2028-12-31
Clinical trial NCT07218094 updates: 1. completion date: 2026-02-01 → 2027-02-01 2. primary completion date: 2026-02-01 → 2027-02-01
Clinical trial NCT06355934 updates: 1. completion date: 2026-09-30 → 2026-11-02 2. primary completion date: 2026-09-30 → 2026-11-02
Clinical trial NCT07116395: start date: 2026-01-01 → 2027-01-01.
Clinical trial NCT02436707: primary completion date: 2026-06-30 → 2026-12-31.